|
US2012302954A1
|
|
Expandable devices coated with a paclitaxel composition
|
|
US2010233236A1
|
|
Drug coated expandable devices
|
|
US2010131050A1
|
|
Absorbable stent having a coating for controlling degradation of the stent and maintaining pH neutrality
|
|
US2009214615A1
|
|
Layer-by-layer stereocomplexed polymers as drug depot carriers or coatings in medical devices
|
|
US2009125101A1
|
|
Polymeric materials for medical devices
|
|
US2009018646A1
|
|
Coating Employing an Anti-Thrombotic Conjugate
|
|
US2008243241A1
|
|
Short term sustained drug-delivery system for implantable medical devices and method of making the same
|
|
US2008200421A1
|
|
Coating for a medical device having an anti-thrombotic conjugate
|
|
US2008188925A1
|
|
Antithrombotic and anti-restenotic drug eluting stent
|
|
US2006292077A1
|
|
Dendritic and star-shaped contrast agents for medical devices and bioabsorbable radiopaque bulk material and method for producing same
|
|
US2007203168A1
|
|
Isomers of rapamycin and 42-Epi-rapamycin, methods of making and using the same
|
|
US2007203171A1
|
|
Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same
|
|
US2007203169A1
|
|
Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same
|
|
US2007225313A1
|
|
Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same
|
|
US2006264531A1
|
|
Biodegradable medical devices with enhanced mechanical strength and pharmacological functions
|
|
US2007155907A1
|
|
Biologically active block copolymers
|
|
US2007134163A1
|
|
Radiographic contrasting agents and radio-opaque polymeric materials for medical devices
|
|
US2007135908A1
|
|
Absorbable stent comprising coating for controlling degradation and maintaining pH neutrality
|
|
US2007128289A1
|
|
Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases
|
